gilteritinib sold brand name xospata anticancer acts inhibitor hence tyrosine kinase developed astellas pharma april astellas filed new drug application food drug administration gilteritinib treatment adult patients relapsed refractory acute myeloid leukemia november fda approved gilteritinib treatment adult patients relapsed refractory acute myeloid leukemia aml mutation detected fdaapproved gilteritinib granted orphan drug status us fda european commission ec japan ministry health labor welfare aml gilteritinib approved medical use australia march antineoplastic immunomodulatory drug article stub help wikipedia expanding httpsenwikipediaorgwikigilteritinib